Your browser doesn't support javascript.
loading
Visualizing Localized Reentry With Ultra-High Density Mapping in Iatrogenic Atrial Tachycardia: Beware Pseudo-Reentry.
Luther, Vishal; Sikkel, Markus; Bennett, Nathan; Guerrero, Fernando; Leong, Kevin; Qureshi, Norman; Ng, Fu Siong; Hayat, Sajad A; Sohaib, S M Afzal; Malcolme-Lawes, Louisa; Lim, Elaine; Wright, Ian; Koa-Wing, Michael; Lefroy, David C; Linton, Nick W F; Whinnett, Zachary; Kanagaratnam, Prapa; Davies, D Wyn; Peters, Nicholas S; Lim, Phang Boon.
Afiliación
  • Luther V; From the Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom (V.L., M.S., K.L., N.Q., F.S.N., S.A.H., S.M.A.S., L.M.-L., E.L., I.W., M.K.-W., D.C.L., N.W.F.L., Z.W., P.K., D.W.D., N.S.P., P.B.L.); and Boston Scientific Ltd, Marlborough, MA (N
  • Sikkel M; From the Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom (V.L., M.S., K.L., N.Q., F.S.N., S.A.H., S.M.A.S., L.M.-L., E.L., I.W., M.K.-W., D.C.L., N.W.F.L., Z.W., P.K., D.W.D., N.S.P., P.B.L.); and Boston Scientific Ltd, Marlborough, MA (N
  • Bennett N; From the Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom (V.L., M.S., K.L., N.Q., F.S.N., S.A.H., S.M.A.S., L.M.-L., E.L., I.W., M.K.-W., D.C.L., N.W.F.L., Z.W., P.K., D.W.D., N.S.P., P.B.L.); and Boston Scientific Ltd, Marlborough, MA (N
  • Guerrero F; From the Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom (V.L., M.S., K.L., N.Q., F.S.N., S.A.H., S.M.A.S., L.M.-L., E.L., I.W., M.K.-W., D.C.L., N.W.F.L., Z.W., P.K., D.W.D., N.S.P., P.B.L.); and Boston Scientific Ltd, Marlborough, MA (N
  • Leong K; From the Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom (V.L., M.S., K.L., N.Q., F.S.N., S.A.H., S.M.A.S., L.M.-L., E.L., I.W., M.K.-W., D.C.L., N.W.F.L., Z.W., P.K., D.W.D., N.S.P., P.B.L.); and Boston Scientific Ltd, Marlborough, MA (N
  • Qureshi N; From the Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom (V.L., M.S., K.L., N.Q., F.S.N., S.A.H., S.M.A.S., L.M.-L., E.L., I.W., M.K.-W., D.C.L., N.W.F.L., Z.W., P.K., D.W.D., N.S.P., P.B.L.); and Boston Scientific Ltd, Marlborough, MA (N
  • Ng FS; From the Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom (V.L., M.S., K.L., N.Q., F.S.N., S.A.H., S.M.A.S., L.M.-L., E.L., I.W., M.K.-W., D.C.L., N.W.F.L., Z.W., P.K., D.W.D., N.S.P., P.B.L.); and Boston Scientific Ltd, Marlborough, MA (N
  • Hayat SA; From the Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom (V.L., M.S., K.L., N.Q., F.S.N., S.A.H., S.M.A.S., L.M.-L., E.L., I.W., M.K.-W., D.C.L., N.W.F.L., Z.W., P.K., D.W.D., N.S.P., P.B.L.); and Boston Scientific Ltd, Marlborough, MA (N
  • Sohaib SM; From the Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom (V.L., M.S., K.L., N.Q., F.S.N., S.A.H., S.M.A.S., L.M.-L., E.L., I.W., M.K.-W., D.C.L., N.W.F.L., Z.W., P.K., D.W.D., N.S.P., P.B.L.); and Boston Scientific Ltd, Marlborough, MA (N
  • Malcolme-Lawes L; From the Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom (V.L., M.S., K.L., N.Q., F.S.N., S.A.H., S.M.A.S., L.M.-L., E.L., I.W., M.K.-W., D.C.L., N.W.F.L., Z.W., P.K., D.W.D., N.S.P., P.B.L.); and Boston Scientific Ltd, Marlborough, MA (N
  • Lim E; From the Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom (V.L., M.S., K.L., N.Q., F.S.N., S.A.H., S.M.A.S., L.M.-L., E.L., I.W., M.K.-W., D.C.L., N.W.F.L., Z.W., P.K., D.W.D., N.S.P., P.B.L.); and Boston Scientific Ltd, Marlborough, MA (N
  • Wright I; From the Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom (V.L., M.S., K.L., N.Q., F.S.N., S.A.H., S.M.A.S., L.M.-L., E.L., I.W., M.K.-W., D.C.L., N.W.F.L., Z.W., P.K., D.W.D., N.S.P., P.B.L.); and Boston Scientific Ltd, Marlborough, MA (N
  • Koa-Wing M; From the Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom (V.L., M.S., K.L., N.Q., F.S.N., S.A.H., S.M.A.S., L.M.-L., E.L., I.W., M.K.-W., D.C.L., N.W.F.L., Z.W., P.K., D.W.D., N.S.P., P.B.L.); and Boston Scientific Ltd, Marlborough, MA (N
  • Lefroy DC; From the Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom (V.L., M.S., K.L., N.Q., F.S.N., S.A.H., S.M.A.S., L.M.-L., E.L., I.W., M.K.-W., D.C.L., N.W.F.L., Z.W., P.K., D.W.D., N.S.P., P.B.L.); and Boston Scientific Ltd, Marlborough, MA (N
  • Linton NW; From the Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom (V.L., M.S., K.L., N.Q., F.S.N., S.A.H., S.M.A.S., L.M.-L., E.L., I.W., M.K.-W., D.C.L., N.W.F.L., Z.W., P.K., D.W.D., N.S.P., P.B.L.); and Boston Scientific Ltd, Marlborough, MA (N
  • Whinnett Z; From the Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom (V.L., M.S., K.L., N.Q., F.S.N., S.A.H., S.M.A.S., L.M.-L., E.L., I.W., M.K.-W., D.C.L., N.W.F.L., Z.W., P.K., D.W.D., N.S.P., P.B.L.); and Boston Scientific Ltd, Marlborough, MA (N
  • Kanagaratnam P; From the Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom (V.L., M.S., K.L., N.Q., F.S.N., S.A.H., S.M.A.S., L.M.-L., E.L., I.W., M.K.-W., D.C.L., N.W.F.L., Z.W., P.K., D.W.D., N.S.P., P.B.L.); and Boston Scientific Ltd, Marlborough, MA (N
  • Davies DW; From the Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom (V.L., M.S., K.L., N.Q., F.S.N., S.A.H., S.M.A.S., L.M.-L., E.L., I.W., M.K.-W., D.C.L., N.W.F.L., Z.W., P.K., D.W.D., N.S.P., P.B.L.); and Boston Scientific Ltd, Marlborough, MA (N
  • Peters NS; From the Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom (V.L., M.S., K.L., N.Q., F.S.N., S.A.H., S.M.A.S., L.M.-L., E.L., I.W., M.K.-W., D.C.L., N.W.F.L., Z.W., P.K., D.W.D., N.S.P., P.B.L.); and Boston Scientific Ltd, Marlborough, MA (N
  • Lim PB; From the Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom (V.L., M.S., K.L., N.Q., F.S.N., S.A.H., S.M.A.S., L.M.-L., E.L., I.W., M.K.-W., D.C.L., N.W.F.L., Z.W., P.K., D.W.D., N.S.P., P.B.L.); and Boston Scientific Ltd, Marlborough, MA (N
Article en En | MEDLINE | ID: mdl-28356307
ABSTRACT

BACKGROUND:

The activation pattern of localized reentry (LR) in atrial tachycardia remains incompletely understood. We used the ultra-high density Rhythmia mapping system to study activation patterns in LR. METHODS AND

RESULTS:

LR was suggested by small rotatory activations (carousels) containing the full spectrum of the color-coded map. Twenty-three left-sided atrial tachycardias were mapped in 15 patients (age 64±11 years). 16 253±9192 points were displayed per map, collected over 26±14 minutes. A total of 50 carousels were identified (median 2; quartiles 1-3 per map), although this represented LR in only n=7 out of 50 (14%) here, rotation occurred around a small area of scar (<0.03 mV; 12±6 mm diameter). In LR, electrograms along the carousel encompassed the full tachycardia cycle length, and surrounding activation moved away from the carousel in all directions. Ablating fractionated electrograms (117±18 ms; 44±13% of tachycardia cycle length) within the carousel interrupted the tachycardia in every LR case. All remaining carousels were pseudo-reentrant (n=43/50 [86%]) occurring in areas of wavefront collision (n=21; median 0.5; quartiles 0-2 per map) or as artifact because of annotation of noise or interpolation in areas of incomplete mapping (n=22; median 1, quartiles 0-2 per map). Pseudo-reentrant carousels were incorrectly ablated in 5 cases having been misinterpreted as LR.

CONCLUSIONS:

The activation pattern of LR is of small stable rotational activations (carousels), and this drove 30% (7/23) of our postablation atrial tachycardias. However, this appearance is most often pseudo-reentrant and must be differentiated by interpretation of electrograms in the candidate circuit and activation in the wider surrounding region.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Taquicardia por Reentrada en el Nodo Atrioventricular / Taquicardia Supraventricular / Mapeo del Potencial de Superficie Corporal / Enfermedad Iatrogénica Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Circ Arrhythm Electrophysiol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2017 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Taquicardia por Reentrada en el Nodo Atrioventricular / Taquicardia Supraventricular / Mapeo del Potencial de Superficie Corporal / Enfermedad Iatrogénica Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Circ Arrhythm Electrophysiol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2017 Tipo del documento: Article